| Literature DB >> 36238291 |
Yu Wu1,2, Hui Zhou1,2, Kunhua Wei3, Tao Zhang4, Yanyun Che5, Audrey D Nguyễn6, Sakshi Pandita6, Xin Wan1,2, Xuejie Cui1, Bingxue Zhou1, Caiyue Li1,2, Ping Hao1,2, Hongjun Lei1,2, Lin Wang7, Xiaonan Yang3, Ying Liang3, Jiaguo Liu1,2, Yi Wu1,2.
Abstract
A component of licorice polysaccharide (GPS-1) was extracted from licorice, its primary structure was identified and characterized for the first time, and its immunomodulatory activity was studied. Crude licorice polysaccharide was isolated and purified by DEAE sepharose FF ion-exchange column chromatography and Chromdex 200 PG gel filtration column chromatography to obtain a purified Glycyrrhiza polysaccharide named GPS-1. NMR and methylation analysis revealed that GPS-1 is composed of homogalacturonan (HG)-type pectin with 4)-D-GalpA-(1 as the backbone. This study of GPS-1 also examined its significant role in regulating immune activity in vitro and in vivo. As a result, GPS-1 promoted the secretion of IFN-γ and IL-4 in mice and increased the proportion of CD3+CD4+ and CD3+CD8+ T lymphocytes in their spleens. Dendritic cells (DCs) treated with GPS-1 showed promotion of DC maturation, antigen presentation, and phagocytic capacity. The results suggest that GPS-1 is a potential immunomodulator that stimulates the immune system by regulating multiple signaling pathways. Combined with our characterization of the primary structure of GPS-1, the present investigation provides the basis for future study of the form-function relationship of polysaccharides.Entities:
Keywords: dendritic cells; glycyrrhiza polysaccharide; immunomodulatory activity; structural characterization; toll-like receptor
Mesh:
Substances:
Year: 2022 PMID: 36238291 PMCID: PMC9551306 DOI: 10.3389/fimmu.2022.1007186
Source DB: PubMed Journal: Front Immunol ISSN: 1664-3224 Impact factor: 8.786
Figure 1(A) Elution profile of GPS50 ion-exchange column chromatography. (B) Elution profiles of samples GPS-E1 and GPS-E2 gel filtration column chromatography (C) The HPGPC chromatogram of the GPS-1 (left) and GPS-2 (right). (D) The specific flow chart of GPS-1 extraction.
Monosaccharide composition and ratio of GPS-1.
| Monosaccharide | Mass conversion result (ug/mg) | The percentage of each component (%) |
|---|---|---|
| Fuc | 2.84 | 0.92 |
| Ara | 31.20 | 10.12 |
| Rha | 19.59 | 6.36 |
| Gal | 14.94 | 4.85 |
| Glc | 4.12 | 1.34 |
| Xyl | 1.56 | 0.51 |
| Man | None | None |
| Fru | None | None |
| Rib | None | None |
| Gal-UA | 229.23 | 74.39 |
| Gul-UA | None | None |
| Glc-UA | 4.68 | 1.52 |
| Man-UA | None | None |
The sugar residue connection mode of GPS-1.
| Connection method | Derivative name | molecular weight (MW) | relative molar ratio (%) |
|---|---|---|---|
| t-Rha(p) | 1,5-di-O-acetyl-6-deoxy-2,3,4-tri-O-methyl rhamnitol | 293 | 2.336 |
| t-Ara(f) | 1,4-di-O-acetyl-2,3,5-tri-O-methyl arabinitol | 279 | 4.328 |
| t-Fuc(p) | 1,5-di-O-acetyl-6-deoxy-2,3,4-tri-O-methyl fucitol | 293 | 1.174 |
| t-Xyl(p) | 1,5-di-O-acetyl-2,3,4-tri-O-methyl xylitol | 279 | 0.944 |
| 2-Rha(p) | 1,2,5-tri-O-acetyl-6-deoxy-3,4-di-O-methyl rhamnitol | 321 | 1.246 |
| 3-Rha(p) | 1,3,5-tri-O-acetyl-6-deoxy-2,4-di-O-methyl rhamnitol | 321 | 1.123 |
| t-Gal(p) | 1,5-di-O-acetyl-2,3,4,6-tetra-O-methyl galactitol | 323 | 4.051 |
| t-Gal(p)-UA | 1,5-di-O-acetyl-2,3,4,6-tetra-O-methyl galactitol | 323 | 6.076 |
| 5-Ara(f) | 1,4,5-tri-O-acetyl-2,3-di-O-methyl arabinitol | 307 | 2.797 |
| 4-Ara(p) | 1,4,5-tri-O-acetyl-2,3-di-O-methyl Araitol | 307 | 1.352 |
| 4-Gal(p)-UA | 1,4,5-tri-O-acetyl-2,3,6-tri-O-methyl galactitol | 351 | 61.675 |
| 4-Glc(p) | 1,4,5-tri-O-acetyl-2,3,6-tri-O-methyl glucitol | 351 | 1.942 |
| 4-Glc(p)-UA | 1,4,5-tri-O-acetyl-2,3,6-tri-O-methyl glucitol | 351 | 1.942 |
| 6-Gal(p)-UA | 1,5,6-tri-O-acetyl-2,3,4-tri-O-methyl galactitol | 351 | 4.955 |
| 3,4-Glc(p) | 1,3,4,5-tetra-O-acetyl-2,6-di-O-methyl glucitol | 379 | 0.679 |
| 3,4-Glc(p)-UA | 1,3,4,5-tetra-O-acetyl-2,6-di-O-methyl glucitol | 379 | 0.679 |
| 2,4-Gal(p)-UA | 1,2,4,5-tetra-O-acetyl-3,6-di-O-methyl galactitol | 379 | 1.335 |
| 3,6-Gal(p) | 1,3,5,6-tetra-O-acetyl-2,4-di-O-methyl galactitol | 379 | 1.367 |
Figure 2GPS-1 one-dimensional nuclear magnetic resonance spectrum (A) 1H-NMR. (B) 13C-NMR. (C)13C-DEPT.GPS-1 2D NMR spectrum (D) HSQC. (E) 1H-1H COSY. (F) HMBC. (G) NOESY.
Assignment of chemical shifts of 1H and 13C of each sugar residue in GPS-1.
| sugar residue | chemical shift(ppm) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5/5a | 6/5b | CH3- of OMe- | |||
|
| →4)-α-D-Gal | H | 4.96 | 3.62 | 3.87 | 4.29 | 4.64 | ||
| C | 100.43 | 69.66 | 70.21 | 79.26 | 72.83 | 176.94 | |||
|
| →4)-α-D-Gal | H | 4.80 | 3.62 | 3.85 | 4.44 | 5.02 | 3.67 | |
| C | 101.55 | 69.66 | 70.09 | 80.24 | 72.12 | 172.20 | 54.40 | ||
|
| →5)-α-L-Ara | H | 4.95 | 4.00 | 3.82 | 3.95 | 3.67 | 3.76 | |
| C | 108.90 | 82.71 | 78.05 | 85.57 | 68.17 | ||||
|
| α-L-Ara | H | 5.04 | 4.00 | 3.88 | 4.09 | 3.59 | 3.71 | |
| C | 108.47 | 82.71 | 78.32 | 83.93 | 62.68 | ||||
| Rα | →4)-α-D-Gal | H | 5.18 | 3.70 | 3.86 | 4.26 | – | ||
| C | 93.69 | 69.38 | 70.09 | 78.87 | – | 176.49 | |||
| Rβ | →4)-β-D-Gal | H | 4.47 | 3.36 | 3.60 | 4.23 | 3.93 | ||
| C | 97.65 | 72.83 | 71.73 | 78.99 | 75.69 | 176.49 | |||
Molecular weight results for GPS-1.
| RT(min) | lgMp | lgMw | lgMn | Mp | Mw | Mn | Mw/Mn |
|---|---|---|---|---|---|---|---|
| 40.567 | 4.371 | 4.422 | 4.255 | 23505 | 26440 | 17980 | 1.47 |
Figure 3The structural model of GPS-1.
Figure 4(A) Expression levels of IFN-γ and IL-10 in serum of mice in each group after 14 days of administration (n = 5). (B) Histological analysis diagram of each small intestinal segment (200×),. and thymus and spleen (100×) at 14 days after drug administration. (C) Expression of CD3+CD4+ and CD3+CD8+ T cells in mouse spleen lymphocytes 14 days after administration (n = 5) and representative flow scatter plots of CD3+CD4+ and CD3+CD8+ T lymphocytes.Compared with blank group (Control): **p<0.01, ***p<0.001.
Figure 5(A) The effect of GPS-1 on the activity of mouse DCs (n=6). (B) The effect of GPS-1 on cytokine secretion by DCs (n=4). (C) Flow cytometry and scatter diagram of GPS-1 enhancing the phagocytosis of DCs. (D) Confocal image of GPS-1 enhancing phagocytosis of DCs and statistics of fluorescence intensity. (E) GPS-1 increases the expression of CD80 and CD86 on the surface of DCs and the scatter plot.(F) GPS-1 increases the expression of CD80 and CD86 on DCs surface flow statistics. Compared with blank group (Control): *p<0.05, **p<0.01, ***p<0.001; compared with positive control group (LPS): #P<0.05, ##P<0.01, ###P<0.001.
Figure 6(A) Heat map of expression correlation of samples in different groups. (B) Differential gene expression volcano map. (C) Differential gene expression heat map. (D) Statistical chart of GO annotation classification of differentially expressed genes. (E) Bubble plot of differentially expressed genes KEGG enrichment.